United States: Highlights From The 2015 OIG Work Plan

The Office of Inspector General (OIG) of the Department of Health and Human Services (HHS) released its Work Plan for Fiscal Year 2015 on October 31, 2014. Typically issued in October of each year, the work plan provides an annual view into the OIG's planned areas of focus for investigation and enforcement activities in the coming year.

Below are a few interesting observations from this year's work plan. The work plan itself contains a number of other areas under review and is worth reading to understand specific concerns in areas not mentioned below.

1. Hospital Inpatient Admission Criteria – "Two Midnight Rule"

The OIG intends to review the impact of new inpatient admission criteria on hospital billing, Medicare payments and beneficiary copayments. Specifically, OIG intends to review how billing varied among hospitals in the 2014 fiscal year. The new inpatient admission criteria took effect in fiscal year 2014, after the OIG identified millions of dollars in overpayments to hospitals for short inpatient stays that should have been billed as outpatient stays. The new inpatient admission criteria states that physicians should admit for inpatient care only those beneficiaries who are expected to need at least two nights of hospital care (the "two midnight policy"). Beneficiaries requiring care that is expected to last fewer than two nights are to be treated as outpatients. Hospitals should review the new inpatient admission criteria and ensure their actions comply with the two midnight policy. The OIG is expected to issue a report in 2016 on the impact of the new inpatient criteria on hospital billing.

2. Provider-Based Facilities

The OIG intends to continue its focus on provider-based facilities through its review of such facilities as we discussed in our summary of the 2014 OIG Work Plan. Provider-based facilities are hospital outpatient departments and often are located off-campus. The facilities tend to be paid more than freestanding clinics are for similar Medicare services, in recognition of the generally higher levels of overhead and infrastructure necessary to qualify as a hospital-based facility. Unlike at physician practice clinics, services at a provider-based facility are reimbursed for both a technical fee (for the hospital) and a professional fee (for the physician). The OIG continues to review the extent to which provider-based facilities meet the provider-based criteria set by the Centers for Medicare and Medicaid Services (CMS). In addition, the OIG plans to continue to review and compare Medicare payments for physician office visits in provider-based facilities and freestanding clinics to determine the potential impact on the Medicare program of these different payments and whether they are justified. Hospitals operating provider-based facilities should continue to ensure that they comply with all Medicare provider-based rules.

3. Outpatient Evaluation and Management (E&M) Codes

The OIG intends to review Medicare outpatient payments for E&M services to determine whether such services were appropriately coded as "new" or "established." The OIG stated that preliminary work indicates that overpayments have occurred as a result of hospitals indicating that a patient was "new" when the patient should have been coded as "established" under the federal regulations. Federal regulations distinguish between "new" and "established" patients based on whether the patient has been seen as a registered inpatient or outpatient of the hospital within the preceding three years.

4. Hospital Wage Data

The OIG added a new review of hospital controls over their wage data reporting in this year's work plan. This reported data is used by CMS to calculate the hospital wage index for Medicare payments in calculations of each hospital's inpatient prospective payment system payment. To determine the wage index, hospitals must report wage data to CMS annually. Prior OIG wage index work identified hundreds of millions of dollars in incorrectly reported wage data and resulted in policy changes by CMS with regard to how hospitals reported deferred compensation costs. The OIG appears to be reviewing those efforts of CMS to see if these policy changes have had an impact on the Medicare system. Hospitals should always make sure that they are reporting accurate information to CMS, but this year may be an important time to self-audit and reevaluate wage index information before the hospital submits its next report.

5. Medicare Dental Claims in Hospitals

The OIG continues its various reviews of Medicare hospital outpatient payments for dental services to determine whether such payments were made in accordance with Medicare requirements. Dental services generally are excluded from Medicare coverage with certain exceptions, such as extraction of teeth to prepare the jaw for radiation treatment. Current OIG audits have suggested that hospitals are receiving Medicare reimbursement for non-covered dental services, resulting in significant overpayments. As such, the OIG continues to investigate and review past Medicare dental billing by hospitals. Before billing, any such Medicare claim should be verified as appropriate under the Medicare program.

6. Medicaid Pediatric Dental Services

The OIG plans to continue its focus on Medicaid pediatric dental services through two work plan items. First, the OIG will continue to review Medicaid payments by states for dental services to determine whether states properly claimed federal reimbursement. Past reports found 31 percent of dental services "resulted in improper payments" (although most were documentation errors). Second, the OIG will continue to review whether children enrolled in Medicaid receive all of their intended dental service benefits. Medicaid covers approximately 37 million low-income children through the program's early and periodic screening, diagnosis and treatment program. Past OIG reports found three out of four children had not received all of their required screenings, and the OIG notes that children's dental access has been a longstanding Medicaid problem. On the other hand, the OIG notes in its work plan that a number of dental providers and dental chains have been prosecuted in recent years for providing unnecessary dental procedures, and Congress has released reports questioning certain dental practices' behaviors. A final report on either of these topics may help to set a direction for policymakers in these areas to expand access to Medicaid dental services. In the meantime, dental providers should continue their efforts to ensure proper compliance.

7. Oversight of Pharmaceutical Compounding

The OIG will review Medicare's oversight of Medicare-participating acute care hospitals and the recommended practices for pharmaceutical compounding oversight. The work plan notes that most hospitals compound pharmaceuticals onsite and that the accreditation and certification process, which is overseen by Medicare, is particularly important in light of the fact that the 2012 meningitis outbreak resulted from contaminated injections of compounded drugs. Oversight over hospital pharmaceutical compounding was a new initiative for the OIG in its 2014 Work Plan, and commentators have stated that the increased scrutiny leaves hospitals with a difficult choice: minimize risk by outsourcing compounding requirements but lose oversight over quality assurance, or, alternatively, perform the compounding in house with greater costs and resources being expended on quality assurance.

8. Questionable Billing Patterns for Part B Services During Nursing Home Stays

The OIG will investigate questionable billing practices associated with nursing homes for Medicare Part B services provided to nursing home residents during stays that are not paid under Part A (e.g., stays during which benefits are exhausted or stays where the three-day prior inpatient stay requirement has not been met). The OIG will perform a series of studies to examine broad categories of services, such as foot care, and monitor Part B billing to ensure no excessive services are provided. The OIG released a report in 2012 after performing a similar investigation on home health service billing for the year 2010 and found that Medicare inappropriately paid $5 million for home health services in 2010. The 2012 report suggested CMS perform stricter monitoring and enforcement in this area to address the issue.

9. Equipment and Supplies – Policies and Practices

Power mobility devices – Lump-sum purchase versus rental
The OIG will investigate whether savings can be achieved if certain power mobility devices are rented over 13-month periods, rather than acquired through lump-sum purchases. CMS already has begun moving toward 13-month rentals, as most power wheelchairs furnished on or after January 1, 2011, receive Medicare payments only on a rental basis. This also is consistent with how other forms of durable medical equipment are reimbursed by Medicare.

Competitive bidding for medical equipment items and services − Mandatory post-award audit
The OIG will review the process CMS used to conduct competitive bidding and to make pricing determinations for certain medical equipment items and services in selected competitive bidding areas under rounds one and two of the competitive bidding program. A previous OIG report on this topic, released in April 2014, found that CMS generally selected suppliers and computed payment amounts in accordance with federal requirements in round one of the rebid program. The OIG is required by law to conduct these post-award audits to access the competitive bidding process.

Competitive bidding for diabetes testing supplies − Market share review
The OIG will determine the market share for different types of diabetes test strips for the three-month period from October 2013 to December 2013, as required under the Medicare Improvements for Patients and Providers Act (MIPPA). Under MIPPA, CMS may award contracts for mail-order diabetes test strips only to suppliers who demonstrate their bid covers at least 50 percent, by volume, of all types of diabetes test strips in rounds subsequent to round one of the rebid of the competitive bidding program. The OIG most recently examined a sample of 1,210 diabetes test strips associated with Medicare claims for the period from July 2013 to September 2013 and found that 22 suppliers submitted at least 43 types of mail-order diabetes test strips, but two types of test strips accounted for approximately 45 percent of the mail-order market share, three types of strips accounted for 59 percent of the market share, and 10 types accounted for 90 percent. CMS will use the results of this study to analyze the program and evaluate the effect of the competitive bidding program on test-strip choice.

10. Ambulatory Surgical Centers − Payment Systems

As reviewed in last year's OIG Work Plan client alert, the OIG will continue reviewing the appropriateness of Medicare's methodology for setting ambulatory surgical center (ASC) payment rates. The OIG also intends to review whether payment disparities exist between ASC and hospital outpatient payment rates for similar surgical procedures. Previous OIG reports estimated that Medicare saved almost $7 billion during calendar years (CYs) 2007 through 2011 and potentially could save $12 billion from CYs 2012 through 2017 because ASC rates frequently are lower than outpatient department rates for surgical procedures. The OIG is expected to release its report later this year.

11. End Stage Renal Disease (ESRD) Bundled Payments

The OIG will continue reviewing payments for ESRD services and drugs under its bundled prospective payment system (PPS) rate. The OIG's efforts are part of a 2011 federal law requiring CMS to begin implementing a system bundling all of the costs of ESRD care. The OIG uses data on facility acquisition costs and inflation-adjusted estimates to determine how costs for ESRD drugs have changed. The OIG's findings may impact future calls for ESRD payment changes.

12. Anesthesia Services – Payments for Personally Performed Services

The OIG has renewed its efforts to investigate Medicare Part B claims for personally performed anesthesia services (service code AA) to determine whether such claims are supported in accordance with Medicare requirements. The OIG noted once again that personally performed services are billed at a rate double that of services performed under an anesthesiologist's medical direction (service code QK), and that incorrect coding results in Medicare paying a higher amount. As was the case last year, anesthesiologists working with nurse anesthetists should ensure that they have proper documentation for all services personally performed (AA), but should use the QK modifier if the patient is left in the care of a nurse anesthetist at any time. As further evidence of its continued focus on proper billing for anesthesia services, on October 30, 2014, the day prior to the release of its 2015 Work Plan, the OIG released an audit report detailing that a New Jersey-based hospital received $1.7 million in Medicare overpayments from April 2011 through September 2012.

13. Chiropractic Services

The OIG intends to review Medicare Part B payments to determine if claims were submitted appropriately. Medicare covers correction only of certain conditions and does not cover services that are not reasonable and necessary, which, under CMS' definition, includes chiropractic maintenance. Further, the OIG intends to investigate the extent of questionable billing for chiropractic services. Existing data shows high claim error rates amongst certain providers. The OIG intends to compile existing chiropractic billing data to identify and offer recommendations for areas of high fraud vulnerability.

14. Independent Clinical Laboratory Billing Requirements

The OIG will review Medicare payments to independent clinical laboratories to determine laboratories' compliance with Medicare billing requirements. Medicare is the largest payer of clinical laboratory services in the nation. From 2005 to 2010, Part B Medicare enrollment increased by 10 percent, while spending for laboratory services increased by 29 percent. In 2010, Medicare payments for all Part B lab services totaled $8.2 billion. With this rise in laboratory payments, independent clinical laboratories increasingly have become the subject of OIG audits, investigations and inspections. Independent clinical laboratories should strictly comply with the Medicare billing requirements, because we expect OIG audits, investigations and inspections will continue in the coming years. The OIG is expected to release a review later this year on Medicare payments to independent clinical laboratories.

15. Long-Term Care Hospital Adverse Events

The OIG added a new review that will estimate the national incidence of adverse and temporary harm events for Medicare beneficiaries receiving care in long-term care hospitals (LTCHs). LTCHs are inpatient hospitals that provide long-term care with an average length of stay greater than 25 days for their Medicare patients. A Medicare beneficiary typically enters an LTCH following an acute care hospital stay and pays no additional deductible. A beneficiary admitted directly from the community (i.e., not post-hospital stay) is responsible for a deductible. As LTCHs are the third most common type of post-acute care facility, the OIG is concerned that adverse events in these settings are having a negative impact on a significant number of patients and costing serious dollars. The OIG anticipates determining the extent to which these events are preventable and will provide key factors causing the events. LTCHs will want to implement any changes proposed in these reports in the years to come to avoid preventable harm.

For more background, please see our alerts ( part 1 and part 2) from earlier this year regarding the 2014 OIG Work Plan.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
Similar Articles
Relevancy Powered by MondaqAI
 
In association with
Related Topics
 
Similar Articles
Relevancy Powered by MondaqAI
Related Articles
 
Related Video
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
 
Email Address
Company Name
Password
Confirm Password
Position
Mondaq Topics -- Select your Interests
 Accounting
 Anti-trust
 Commercial
 Compliance
 Consumer
 Criminal
 Employment
 Energy
 Environment
 Family
 Finance
 Government
 Healthcare
 Immigration
 Insolvency
 Insurance
 International
 IP
 Law Performance
 Law Practice
 Litigation
 Media & IT
 Privacy
 Real Estate
 Strategy
 Tax
 Technology
 Transport
 Wealth Mgt
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.

Disclaimer

The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.

General

Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions